Related Experiment Videos
Analgesics for pediatric use
1Department of Clinical Pharmacology, PGIMER, Chandigarh.
Indian Journal of Pediatrics
|September 14, 2000
Summary
Nimesulide use is rising, with serious liver damage concerns, especially in children. Post-marketing surveillance is crucial to prevent adverse drug reactions in developing countries.
Area of Science:
- Pharmacology
- Hepatology
- Pediatrics
Background:
- Nimesulide usage is increasing globally.
- Concerns regarding nimesulide-induced hepatotoxicity, particularly in pediatric populations, have emerged.
- Two fatalities linked to fulminant hepatic failure have been reported.
Observation:
- Nimesulide is approved in India, with multiple pediatric formulations available.
- Post-marketing surveillance systems for adverse drug reactions in India are lacking effective mechanisms for detection and reporting.
Findings:
- The increasing prevalence of nimesulide and inadequate surveillance pose risks.
- Potential for undetected adverse drug reactions, including severe hepatotoxicity, is high.
Implications:
- Rapid approval of drugs like nimesulide, especially when alternatives exist, may be inadvisable in India and other developing nations.
- Strengthening post-marketing surveillance is essential to ensure pediatric drug safety.
- Risk-benefit assessments for nimesulide in pediatric populations require careful consideration.